121 related articles for article (PubMed ID: 38518555)
1. Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.
Toya R; Fukugawa Y; Saito T; Matsuyama T; Yoshida R; Murakami D; Orita Y; Nakayama H; Oya N
Oral Oncol; 2024 Apr; 151():106752. PubMed ID: 38518555
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.
Toya R; Saito T; Yamaguchi K; Matsuyama T; Watakabe T; Matsumoto T; Yoshida R; Hirosue A; Murakami D; Orita Y; Nakayama H; Oya N
Radiat Oncol; 2020 May; 15(1):123. PubMed ID: 32460865
[TBL] [Abstract][Full Text] [Related]
3. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
Kil WJ; Camphausen K
Head Neck; 2017 Apr; 39(4):E55-E60. PubMed ID: 28170130
[TBL] [Abstract][Full Text] [Related]
4. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
[TBL] [Abstract][Full Text] [Related]
5. Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.
Hughes RT; Gebeyehu RR; Kalada JM; Lycan TW; Frizzell BA; Kinney RD; D'Agostino RB; Bunch PM; Triozzi P; Zhang W; Furdui CM; Porosnicu M
Future Oncol; 2023 Jul; 19(22):1523-1534. PubMed ID: 37199326
[TBL] [Abstract][Full Text] [Related]
6. Conventional Fractionation versus Quad Shot in Advanced Head-and-Neck Cancers: A Randomized Controlled Trial.
Choudhary A; Gupta A
Indian J Palliat Care; 2019; 25(4):527-534. PubMed ID: 31673207
[TBL] [Abstract][Full Text] [Related]
7. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.
Lok BH; Jiang G; Gutiontov S; Lanning RM; Sridhara S; Sherman EJ; Tsai CJ; McBride SM; Riaz N; Lee NY
Oral Oncol; 2015 Oct; 51(10):957-62. PubMed ID: 26282714
[TBL] [Abstract][Full Text] [Related]
8. Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens.
Finnegan TS; Bhatt NH; Shaughnessy JN; Perez C; Redman R; Silverman C; Bumpous J; Potts K; Dunlap NE
J Community Support Oncol; 2016 Jan; 14(1):29-36. PubMed ID: 26870840
[TBL] [Abstract][Full Text] [Related]
9. QUAD SHOT - an effective hypofractionated palliative radiotherapy in patients with non-melanoma skin cancer. A single-institution experience.
Graczyk Ł; Bibik R; Woźniak A; Jesień-Lewandowicz E; Ciupis J; Szyburski M; Bajer J; Chałubińska-Fendler J; Fijuth J; Jońska-Gmyrek JG
Contemp Oncol (Pozn); 2023; 27(2):80-89. PubMed ID: 37794986
[TBL] [Abstract][Full Text] [Related]
10. Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.
Fan D; Kang JJ; Fan M; Wang H; Lee A; Yu Y; Chen L; Jillian Tsai C; McBride SM; Riaz N; Gelblum DY; Neal BP; Fetten J; Dunn LA; Michel LS; Boyle JO; Cohen MA; Roman BR; Ganly I; Singh B; Wong RJ; Sherman EJ; Lee NY
Oral Oncol; 2020 May; 104():104641. PubMed ID: 32182548
[TBL] [Abstract][Full Text] [Related]
11. QUAD shot: an effective cyclical hypofractionated palliative radiotherapy for salivary gland carcinoma.
Toya R; Saito T; Matsuyama T; Watakabe T; Yamaguchi K; Murakami D; Honda Y; Mizutari S; Orita Y; Oya N
BJR Case Rep; 2020 Dec; 6(4):20190132. PubMed ID: 33299577
[TBL] [Abstract][Full Text] [Related]
12. Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment.
Moncharmont C; Vallard A; Mengue Ndong S; Guy JB; Saget C; Méry B; Langrand-Escure J; de Laroche G; Goyet D; Prades JM; Fournel P; Magné N
Acta Otolaryngol; 2016; 136(2):181-8. PubMed ID: 26503806
[TBL] [Abstract][Full Text] [Related]
13. Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot.
Ma J; Lok BH; Zong J; Gutiontov SI; Cai X; Bell AC; Shcherba M; Xiao H; Sherman EJ; Tsai CJ; Riaz N; McBride SM; Cahlon O; Lee NY
Int J Part Ther; 2018; 4(4):10-19. PubMed ID: 30246055
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
15. Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?
Buciuman N; Marcu LG
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5311-5321. PubMed ID: 35598230
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy and hypofractionated volumetric modulated arc therapy for elderly patients with breast cancer: comparison of acute and late toxicities.
Fiorentino A; Gregucci F; Mazzola R; Figlia V; Ricchetti F; Sicignano G; Giajlevra N; Ruggieri R; Fersino S; Naccarato S; Massocco A; Corradini S; Alongi F
Radiol Med; 2019 Apr; 124(4):309-314. PubMed ID: 30547358
[TBL] [Abstract][Full Text] [Related]
17. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen".
Gamez ME; Agarwal M; Hu KS; Lukens JN; Harrison LB
Anticancer Res; 2017 Feb; 37(2):685-691. PubMed ID: 28179317
[TBL] [Abstract][Full Text] [Related]
19. The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT).
Navran A; Heemsbergen W; Janssen T; Hamming-Vrieze O; Jonker M; Zuur C; Verheij M; Remeijer P; Sonke JJ; van den Brekel M; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():25-31. PubMed ID: 30005953
[TBL] [Abstract][Full Text] [Related]
20. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
